GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Standard BioTools Inc (STU:FLB) » Definitions » Sale Of Investment

Standard BioTools (STU:FLB) Sale Of Investment : €164.7 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Standard BioTools Sale Of Investment?

Standard BioTools's sale of investment for the three months ended in Mar. 2024 was €103.0 Mil. It means Standard BioTools gained €103.0 Mil from selling investments. Standard BioTools's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €164.7 Mil.

Compared with last quarter (€23.8 Mil in Dec. 2023 ), Standard BioTools gained more money from selling investments in Mar. 2024 (€103.0 Mil).


Standard BioTools Sale Of Investment Historical Data

The historical data trend for Standard BioTools's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard BioTools Sale Of Investment Chart

Standard BioTools Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.04 30.26 - 50.03 108.17

Standard BioTools Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.63 37.81 - 23.84 103.04

Standard BioTools Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €164.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Standard BioTools Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Standard BioTools's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard BioTools (STU:FLB) Business Description

Traded in Other Exchanges
Address
2 Tower Place, Suite 2000, South San Francisco, CA, USA, 94080
Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Standard BioTools (STU:FLB) Headlines

No Headlines